Exploring all the dimensions of the child's brain

One of the Institute's major strengths is that it brings together research teams - mainly joint Inserm / Université Paris Cité / CEA / Institut Pasteur - that explore all aspects of the child's brain, drawing on a wide range of skills and expertise. The aim is to create synergies, share knowledge and pool equipment.

By bringing together researchers, doctors and patients from the Robert-Debré AP-HP hospital in the same building by 2027, the institute will have every chance of finding and implementing new diagnostics and treatments.

Research - Institut Robert-Debré du Cerveau de l’Enfant

The Institute's research fields

1. Identifying mechanisms of vulnerability in neurodevelopment

Research - Institut Robert-Debré du Cerveau de l’Enfant

This axis, which encompasses the preclinical aspects of the Institute, has as its main objective the understanding of the mechanisms of neurodevelopmental vulnerability and the discovery of new treatments, via :

Modeling brain development;
A new generation of genetic and epigenetic tests;
Identifying risk and resilience factors for neurodevelopmental vulnerabilities.

1. Identifying mechanisms of vulnerability in neurodevelopment

Brain development follows a complex spatio-temporal program. This process can be hampered by pre-, peri- or post-natal brain lesions, caused by strokes, tumors, fetal or maternal infections, head trauma and prematurity. These lesions result in severe neurological deficits of motor, sensory or cognitive type, which are at the root of neurodevelopmental disorders.

This axis, which encompasses the preclinical aspects of the Institut Robert-Debré du Cerveau de l’Enfant, has as its main objective the understanding of the mechanisms of neurodevelopmental vulnerability and the discovery of new treatments.

To achieve this goal, it will address:

Modeling brain development using neuronal cells derived from induced pluripotent stem cells, organoids and animal models.

The development of a new generation of genetic and epigenetic tests for individuals with neurodevelopmental vulnerabilities, using a combination of genomic, epigenetic and phenotypic data.

Identifying risk and resilience factors for neurodevelopmental vulnerabilities.

Leaders

Vincent El Ghouzzi, Robert-Debré Child Brain Institute

Vincent El Ghouzzi

Inserm, NeuroDiderot

A neurobiology researcher, he co-directs the Inserm "NeuroDev" team on neurodevelopmental and neuroendocrine diseases at NeuroDiderot, focusing on rare genetic diseases associated with neurodevelopmental disorders, notably microcephaly. His research focuses in particular on cortical modeling of these diseases using patient-derived pluripotent stem cells (hiPS cells) to better understand the underlying mechanisms and identify therapeutic targets.
See his publications

Valerie Mezger, Robert-Debré Child Brain Institute

Valérie Mezger

Université Paris-Cité, CNRS

Valérie Mezger is a neuroscientist specializing in children's brain development and cognition. She studies the interactions between brain development, brain functional integrity and environmental stress. She focuses in particular on the role of cellular stress response pathways and their impact on neurodevelopmental pathologies, as well as neuronal differentiation under prenatal stress.
See her publications

Stéphane Auvin, Institut Robert-Debré du Cerveau de l’Enfant

Stéphane Auvin

Stéphane Auvin is a neuropediatrician and epileptologist. He is Professor of Pediatric Neurology at Université Paris Cité. He is Director of the Pediatric Neurology Department and Director of the Rare Epilepsy Center at Hôpital Robert-Debré AP-HP, and a member of the EpiCARE ERN network. His clinical and research activities focus on early pediatric epilepsy and epilepsy drug development. His translational research team works on early epilepsy and neurotransmission in the developing brain for new targeted therapies.
See his publications

Research teams

Robert-Debré site: INSERM NeuroDiderot / UPCité: Pierre Gressens
https://neurodiderot.u-paris.fr/equipes-de-recherche/

Fer à Moulin site: INSERM IFM / Sorbonne University: Fiona Francis
https://ifm-institute.org/en/home/

Grands Moulins site: CNRS / UPCité: Valérie Mezger
https://epigenetics.u-paris.fr/fr/valerie-mezger/

Institut Pasteur site: Thomas Bourgeron
https://research.pasteur.fr/fr/team/human-genetics-and-cognitive-functions/

Evry site: i-Stem / INSERM: Alexandra Benchoua
https://istem.eu/

Partners

Platforms: U1141 Human Brain Organoid platform HumBO, U1270 Stem cells in Neurodevelopment, I-Stem
Academic institutions: INSERM, Université Paris Cité, AP-HP, Pasteur
Patient associations : GRAPS (Group of patient associations concerned by science)

2. Understanding children's brain and cognitive development

Research - Institut Robert-Debré du Cerveau de l’Enfant

The aim of this axis is to improve the description of cerebral and cognitive phenotypes, by :

The development of the next generation of anatomical and functional brain imaging techniques for use in young children and school-age children;
Modeling cognition and learning, particularly in the fields of sensorimotricity, social cognition, executive functions, oral and written language, and mathematics;
Characterization of inter-individual variability in brain development (structural and functional), cognitive and behavioral trajectories, the role of the socio-economic environment and points of divergence in neurodevelopmental disorders.

2. Understanding children's brain and cognitive development

The hallmark of childhood is its fantastic capacity for learning. It is the period of life when learning is most rapid and complex.

Whether you're learning a language, a musical instrument, a sport or a new concept, it's best to start early. Why? Because the brain, that remarkable learning machine, develops intensely at this time of life, and is highly plastic!

During the first year, when a young child is learning to walk, talk, recognize family members, etc., all parents notice the changes from week to week, but they are less aware of their baby's intense thinking activity: he or she looks, listens, pays attention, remembers, guesses, plans, chooses and hopes from the very first weeks of life. This early learning within the family is crucial for the future, as it forms the basis for later learning at school.

This is why the Institut Robert-Debré du Cerveau de l’Enfant focuses on early childhood, on those first years that are so important for understanding the mechanisms of human cerebral and cognitive development, its similarities and particularities compared to other animals, but also on the diversity of developmental trajectories. Why this or that difficulty? How to explain it, and above all how to help the child, especially at school.

The great advance of recent years has been the arrival of brain imaging, which enables us to see the anatomical organization of the brain and observe how it reacts to an image or sound, as well as how it is activated when the person is thinking, imagining or learning.

Although much remains to be discovered, brain imaging and the numerous results obtained in experimental psychology have considerably modified models of learning and development.

The Robert-Debré du Cerveau de l’Enfant Institute will draw on the complementarity between teams at Robert-Debré Hospital, the Laboratoire de Psychologie du Développement et de l'Éducation de l'Enfant (LaPsyDÉ) and NeuroSpin's research laboratories, renowned for their methodological expertise in magnetic resonance imaging (MRI) data acquisition and processing, and their imaging studies providing models of cognition and brain development in infants and children. The aim of WP2 is to improve the description of cerebral and cognitive phenotypes. Several axes are therefore planned:

The development of the next generation of anatomical and functional brain imaging techniques for use in young children and school-age children.

Modeling cognition and learning, particularly in the areas of sensorimotricity, social cognition, executive functions, oral and written language, and mathematics.

Characterization of inter-individual variability in brain development (structural and functional), cognitive and behavioral trajectories, the role of the socio-economic environment and points of divergence in neurodevelopmental disorders.

This WP will draw on Neurospin's MRI expertise, particularly in very high magnetic fields (MRI at 7T is starting to be used in children, and NeuroSpin and CEA teams have created a unique MRI for humans, at 11.7T), but also on advances in electrophysiology (EEG, MEG) to obtain portable devices.

Through integration with clinicians and families at the Institut Robert-Debré du Cerveau de l’Enfant, WP2 will provide new tools for early detection, detailed characterization of cognitive difficulties and their impact on schooling, and guidance on remediation and compensation.

Leaders

Jessica Dubois, Institut Robert-Debré du Cerveau de l’Enfant

Jessica Dubois

Inserm, NeuroDiderot, NeuroSpin

A neuroscience researcher specializing in infant neurodevelopment, she co-leads the inDEV team (Imaging Neurodevelopmental Phenotypes). Her research focuses on the early organization and maturation of brain networks, using dedicated neuroimaging techniques such as MRI and EEG to explore the impact of perinatal alterations such as prematurity.
See her publications

Caroline Huron, Institut Robert-Debré du Cerveau de l’Enfant

Caroline Huron

Inserm, Learning Planet Institute

Researcher in cognitive neuroscience. She is particularly interested in dyspraxic children, their cognitive and cerebral particularities, and concrete solutions to facilitate their schooling.
See her publications

Arnaud Cachia, Institut Robert-Debré du Cerveau de l’Enfant

Arnaud Cachia

Professor of cognitive neuroscience at Université Paris-Cité and Deputy Director of Lapsydé (CNRS). His research explores how the brain develops and influences cognition and certain psychiatric symptoms. He is interested in the interactions between cerebral constraints during the foetal period and cerebral plasticity mechanisms during childhood and adolescence, while taking into account the influence of genetic and environmental factors, particularly those linked to the socio-economic context.
See his publications

Ghislaine-Dehaene-Lambertz, Institut Robert-Debré du Cerveau de l’Enfant

Ghislaine Dehaene-Lambertz

Director of the CNRS - Inserm - CEA - NeuroSpin developmental neuroimaging laboratory, Ghislaine Dehaene-Lambertz is a pediatrician and CNRS research director in cognitive sciences, specializing in neuroimaging. She heads the developmental neuroimaging team at NeuroSpin, the CEA's brain imaging center in Saclay.
See her publications

Research teams

Unicog Lab INSERM U992/CEA: Stanislas Dehaene
ERL Neuroimagerie Langage CNRS CEA: Ghislaine Dehaene
MEG-CEA: Fosca Al-Roumi
INSERM/Learning Planet Institute: Caroline Huron
Uniact Lab CEA: David Germanaud,
Baobab Lab CEA: Jean-François Mangin, Édouard Duchesnay
INSERM U1141/UPCité/CEA: Jessica Dubois, Lucie Hertz-Pannier
LaPsyDE CNRS UPCité: Arnaud Cachia, Grégoire Borst

Partners

Networks/platforms: Neurospin, Excello Program
Academic institutions: CEA, Collège de France, INSERM, CNRS, AP-HP, Université Paris-Saclay, Université Paris Cité, Ecole CERENE

3. Improving the care and development of every child

Research - Institut Robert-Debré du Cerveau de l’Enfant

This axis aims to build a healthcare pathway focused on the overall well-being of children and their families, by :

Improving diagnosis, prevention and support for children with neurodevelopmental vulnerabilities;
Setting up a single multimodal, longitudinal care pathway for the most vulnerable children;
The development of a platform to implement clinical trials in children;
Setting up a Living Lab.

3. Improving the care and development of every child

The Institut Robert-Debré du Cerveau de l’Enfant aims to support the development and well-being of every child at every moment of his or her life, taking into account the diversity of individual trajectories in the wider context of society, and of their daily lives, at home, at nursery, at school and in hospital.

Our aim is to provide better support for children's learning and care, by integrating what we know about how the brain works, its cognitive resources and how to overcome its weaknesses.

Ultimately, we want to give every child the opportunity to make the most of his or her individual potential in learning and development, and limit the deleterious impact of any disorders or difficulties the child may have. Our ultimate aim is to improve the quality of learning and the effectiveness of interventions where necessary.

We focus primarily on the early years of life, from birth to the first years of elementary school: a relatively unexplored period when a deeper understanding of neurodevelopment, learning modalities and better care management can bring significant benefits to children's long-term trajectories.

Pragmatically, we want to :

Create a Living Lab to foster innovation and reinforce real evidence of effectiveness

Create a digital portal that promotes screening, information and support for children at nursery, home or school.

Transforming children's healthcare pathways within a better, less unequal and more open hospital organization

Enable the creation of a clinical trials platform for children, and thus support the emergence of new evidence-based therapeutic practices and innovations.

Leaders

Valérie Biran, Robert-Debré Child Brain Institute

Valérie Biran

APHP, INSERM U1141, InDEv Team

A doctoral student at the University of California (UCSF) and professor in the neonatal resuscitation and pediatrics department at Hôpital Robert-Debré for the past fifteen years, she is now head of the department. Her main focus is on research and development of new techniques for assessing brain damage in premature and full-term newborns: neuroimaging, motor and cognitive development.
See her publications

Florentia Kaguelidou, Institut Robert-Debré du Cerveau de l’Enfant

Florentia Kaguelidou

Florentia Kaguelidou is a pediatrician and Professor of Clinical Pharmacology (PU-PH) at the UFR de Médecine, Université Paris Cité. She heads the Clinical Investigation Center (INSERM CIC1426) at Robert Debré University Hospital, a research unit specialized in pediatric clinical trials. Her experience and research focus on clinical trial methodology and pharmaco-epidemiological studies in pediatrics, with a particular interest in the use and assessment of the effects of psychotropic drugs in children.
See her publications

Richard Delorme, Institut Robert-Debré du Cerveau de l’Enfant

Richard Delorme

Head of the Child Psychiatry Department at Hôpital Robert-Debré AP-HP, Richard Delorme is Director of the Center of Excellence for Autism and Neurodevelopmental Disorders (INOVAND). He has extensive experience of child and adolescent psychiatric disorders. He is also a researcher at the Human Genetics and Cognitive Function Unit at the Institut Pasteur (Paris), and was instrumental in identifying the first genes involved in autism, leading to publications in prestigious international journals.
See his publications

Research teams

AP-HP / UPCité (Child psychiatry, Neurology, Neonatology, Genetics, Endocrinology, Radiology, ENT, Functional explorations, Ophthalmology, Autism excellence center) :

Richard Delorme, Stéphane Auvin, Valérie Biran, Anne-Claude Tabet, Alain Verloes, Florentia Kaguelidou, Jean-Claude Carel, Marianne Alison, Christophe Delclaux, Thierry van den Abbeele, Natasha Teissier, Emmanuel Bui-Quoc

Learning Planet Institute (A. Lindner, E. Rotenberg)
Child Mind Institute (B. Leventhal)
UPCité Laboratoire de Psychopathologie et Processus de Santé LPPS (C. Gosslin)
UPCité INSERM U1153 Equipe ECSTRRA (J. Sibeoni)
Clinical Research Unit (Guilmin-Crépon, K. Chevreul, A. Bourmaud)
Clinical Investigation Center (F. Kaguelidou)
Pharmacy (J. Roupret, G. Storme)
Clinical and Translational Applied Neuroimaging Research Unit, Equipe InDEV - CEA NeuroSpin (G. Dehaene-Lambertz, D. Germanaud, J. Houenou, J. Dubois, L. Hertz-Pannier)
Collège de France, CEA, INSERM U992 (S. Dehaene)
Cermes 3 (N. Henckes)
Université Paris 8 Lumières (T. Villemonteix)
Fondamental Foundation (M. Leboyer)
Adult psychiatry (MO Krebs)

Partners

Platforms: DRCI: APHP research platform, Ped-Ecrin European Paediatric Clinical Investigation, HealthCare Living Lab (ICM)

Academic institutions: APHP, CEA, INSERM, CNRS, Collège de France, Université Paris Cité, Institut Pasteur, Ecole Normale Supérieure, national education medical services

Non-profits: UNAPEI, ADHD France, PAARI, Handi-Voice, Autisme Info Service, Le Cartable Fantastique, FFDys

Others: Mairie de Paris, CERENE School, Ifea School

4. Developing predictive models of neurodevelopmental trajectories

Research - Institut Robert-Debré du Cerveau de l’Enfant

The objectives of this axis are as follows:

The creation of an analytical and computational research support team;
The creation of a healthcare data warehouse IHU-Hub bringing together massive imaging, omics and clinical data;
Integrating longitudinal data from publicly available datasets;
The development of statistical and artificial intelligence models to predict children's trajectories at an early age.

4. Developing predictive models of neurodevelopmental trajectories

The strength of the Robert-Debré du Cerveau de l’Enfant Institute will lie in the data collected in an organized structure enabling researchers and clinicians to interrogate data at different scales.

In addition, we will develop predictive models of children's developmental trajectories. Such models are needed to focus remediation efforts on key skills at a given point in their critical plasticity period. Such predictive models require broad-spectrum, high-quality, longitudinal and multi-scale data.

The profound change in the care and education pathway for children with neurodevelopmental vulnerabilities means that existing structures need to be strengthened to create a health data warehouse (bio-bank) that supports the Institute's MindLogger and Care hub's data collection, storage and security efforts to support in-depth research and innovation.

The specific objectives of this axis are as follows:

The creation of an analytical and computational research support team

The creation of a healthcare data warehouse IHU-Hub bringing together massive imaging, omics and clinical data

Integration of longitudinal data from publicly available datasets

The development of statistical and artificial intelligence models to predict children's trajectories at an early age

Leaders

Edouard Duchesnay, Robert-Debré Child Brain Institute

Edouard Duchesnay

CEA, Neurospin, Baobab

Researcher specializing in Machine Learning applied to brain imaging at the Neurospin research center. He supervises a team dedicated to the design of predictive models for psychiatric disorders and manages data regulation for national and European initiatives.
See his publications

Jean-Baptiste Masson, Institute Robert-Debré du Cerveau de l’Enfant

Jean-Baptiste Masson

Physicist Jean-Baptiste Masson is head of the Decision and Bayesian Computation - Epiméthée laboratory (Pasteur, INRIA, CNRS, UPC) within the Neurology and Computational Biology departments of the Institut Pasteur. His multidisciplinary research lies at the frontier between statistical physics, Bayesian machine learning, information theory and bio-medicine.
See his publications

Aurélie Bourmaud, Robert-Debré Child Brain Institute

Aurélie Bourmaud

Public health physician at Hôpital Robert-Debré, Associate Professor at Université Paris Cité and affiliated with Inserm unit IAME 1137. She specializes in epidemiology, prevention and health economics. Her work focuses on prevention, care pathways and the evaluation of complex interventions.
See her publications

Thomas Bourgeron, Institut Robert-Debré du Cerveau de l’Enfant

Thomas Bourgeron

Professor at Université Paris Cité and Institut Pasteur, Thomas Bourgeron discovered the first mutations in the NLGN3, NLGN4X and SHANK3 genes, underlining the key role of the synapse in autism. He heads the Human Genetics and Cognitive Functions unit within the Neuroscience department of the Institut Pasteur, a research group that brings together psychiatrists, neuroscientists and geneticists to understand the interaction between genetic variations associated with autism.
See his publications

Research teams

CEA BAOBAB: Jean-François Mangin, Édouard Duchesnay
AP-HP PRB: Nicolas Deroux
AP-HP: Aurèlie Bourmaud
Institut Pasteur / UPCité: Thomas Bourgeron, JB Masson

Partners

Networks/platforms: Institut Pasteur IT department, FondaMental Foundation, NeuroSpin neuroimaging platform, EDS-APHP Health data warehouse

Academic institutions: APHP, INSERM, Université Paris Cité, Institut Pasteur, CEA